Home › Funds › PFM Health Sciences, LP › GMAB
PFM Health Sciences, LP position in GMAB
GENMAB A/S · Health Care
PFM Health Sciences, LP reported holding 313,679 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$11.2M, representing 1.14% of its reported portfolio and ranking #31 among its reported holdings. PFM Health Sciences, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's GMAB position evolved
PFM Health Sciences, LP first disclosed a stake in GMAB in Q3 2026 at 313,679 shares (US$11.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 313.68K | $11.19M | New |
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 37 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$504.3M), Orbis Allan Gray Ltd (US$377.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 14.14M sh · $504.32M · Q3 2026
- Orbis Allan Gray Ltd 10.57M sh · $376.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.35M sh · $155.17M · Q3 2026
- HARDING LOEVNER LP 2.90M sh · $134.23M · Q3 2026
- Deep Track Capital, LP 2.76M sh · $98.46M · Q3 2026
- DIADEMA PARTNERS LP 518.10K sh · $18.48M · Q3 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held GMAB?
PFM Health Sciences, LP has disclosed GMAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is PFM Health Sciences, LP's current position in GMAB?
As of Q3 2026, PFM Health Sciences, LP holds 313.68K shares of GMAB (GENMAB A/S), valued at $11.19M, representing 1.14% of its reported portfolio and ranking #31.
Has PFM Health Sciences, LP been buying or selling GMAB?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in GMAB.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.